IL6 and infection: In addition, C218‐0546 and STK848198 were also shown to inhibit inflammatory progress by decreasing the production of IL‐1β, IL‐6, and TNFα, while enhancing the production of IL‐10 (Figure S21), which could also be the underlying mechanism of the rapid healing in infection models in vivo after treatment with the compounds.